ScoreWhy is Novelix Pharmaceuticals Ltd ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 171.26%
2
With a growth in Net Sales of 46.53%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 5 consecutive quarters
- NET SALES(9M) Higher at Rs 110.50 cr
- PAT(9M) Higher at Rs 3.09 Cr
3
Market Beating performance in long term as well as near term
- Along with generating 89.95% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Novelix Pharma. should be less than 10%
- Overall Portfolio exposure to Retailing should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Novelix Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Novelix Pharma.
89.95%
1.65
54.51%
Sensex
-3.54%
-0.26
13.41%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
171.26%
EBIT Growth (5y)
26.40%
EBIT to Interest (avg)
0.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
1.18
Tax Ratio
16.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-5.80%
ROE (avg)
0.76%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
64
Industry P/E
37
Price to Book Value
9.10
EV to EBIT
52.31
EV to EBITDA
50.48
EV to Capital Employed
9.59
EV to Sales
1.58
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
4.97%
ROE (Latest)
14.14%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
NET SALES(9M)
Higher at Rs 110.50 cr
PAT(9M)
Higher at Rs 3.09 Cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Novelix Pharma.
Net Sales - Latest six months
At Rs 62.10 cr has Grown at 43.72%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.18 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
